Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.22%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
512.12 Down 3.25(0.63%) May 28, 4:00PM EDT
Add to Portfolio
Prev Close:515.37
Open:512.11
Bid:475.05 x 100
Ask:1,295.72 x 100
1y Target Est:503.74
Beta:0.67
Earnings Date:Aug 3 - Aug 7 (Est.)
Day's Range:509.46 - 514.32
52wk Range:269.50 - 519.46
Volume:702,544
Avg Vol (3m):831,302
Market Cap:52.89B
P/E (ttm):164.30
EPS (ttm):3.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 0.63%52.89B
AMGNDown 1.93%119.64B
NVSUp 0.70%252.32B
RHHBYUp 1.38%N/A

Key Statistics

Forward P/E (1 yr):38.36
P/S (ttm):17.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :11.10
Quarterly EPS Est (Jun-15) :2.75
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback